Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

17

Portfolio Exits

1

Funds

1

About Maryland Momentum Fund

Maryland Momentum Fund was launched by the University System of Maryland (USM) to support startup companies formed from campus research.

Maryland Momentum Fund Headquarters Location

Maryland,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Maryland Momentum Fund News

Linshom Medical, Inc. Closes $1.5 million Series A Round with Investment from Maryland Momentum Fund and Current Investors

May 23, 2022

Linshom is First to Deliver an Operating-Room-Quality Respiratory Profile to Patient Bedside for Continuous, Predictive Respiratory Monitoring (CPRM) Baltimore, Md. (April 27, 2022) – Linshom (“to breathe”), a Maryland-based startup developing a respiratory monitoring system, closed a $1.5 million Series A funding round with investment from the Maryland Momentum Fund and current investors. The Linshom Respiratory Sensor and Monitor is the first predictive, continuous respiratory monitoring system able to practically reach the patients’ bedside. Severe respiratory events can begin to cause brain damage only three minutes after breathing ceases. While critical care patients are continuously monitored for respiratory function, patients on general care floors are not monitored as closely, but are still at risk for serious respiratory complications. The Linshom Respiratory System bridges that gap, helping clinicians respond more quickly to severe respiratory-related events.

Maryland Momentum Fund Investments

17 Investments

Maryland Momentum Fund has made 17 investments. Their latest investment was in Linshom Medical as part of their Series A on April 4, 2022.

CBI Logo

Maryland Momentum Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/27/2022

Series A

Linshom Medical

$1.5M

Yes

2

7/29/2021

Seed VC

Liatris

$1M

Yes

9

6/16/2021

Series A

Veralox Therapeutics

$16.6M

No

11

5/25/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

3/11/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/27/2022

7/29/2021

6/16/2021

5/25/2021

3/11/2021

Round

Series A

Seed VC

Series A

Seed VC - II

Seed VC

Company

Linshom Medical

Liatris

Veralox Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$1.5M

$1M

$16.6M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

9

11

10

10

Maryland Momentum Fund Portfolio Exits

1 Portfolio Exit

Maryland Momentum Fund has 1 portfolio exit. Their latest portfolio exit was InferCabulary on March 10, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/10/2022

Acquired

$99M

1

Date

3/10/2022

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Maryland Momentum Fund Fund History

1 Fund History

Maryland Momentum Fund has 1 fund, including Maryland Momentum Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Maryland Momentum Fund I

$10M

1

Closing Date

Fund

Maryland Momentum Fund I

Fund Type

Status

Amount

$10M

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.